Linked Life Data

16965648

Source:http://linkedlifedata.com/resource/pubmed/id/16965648

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2006-9-12
pubmed:abstractText
Radiofrequency ablation (RFA), which is widely used in treating primary and secondary liver cancer, is regarded as one of the most effective and promising regional therapies to date. However, limited necrosis region and high local recurrence are the major disadvantages of RFA. Researches on RFA are mostly focused on how to widen necrosis regions and decrease local recurrence. This study was to investigate whether RFA combined with ethanol injection (PEI) would widen necrosis region.
pubmed:language
chi
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1000-467X
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1092-6
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
[Radiofrequency ablation combined with ethanol injection for liver cancer treatment---an experimental study].
pubmed:affiliation
State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, 510060, P. R. China.
pubmed:publicationType
Journal Article, English Abstract, Research Support, Non-U.S. Gov't